POCINasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends June 30
PRECISION OPTICS CORPORATION, INC.
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Sep 28, 2026
$4.27−0.05 (-1.16%)
Close on Oct 19, 2026
- Market cap
- $46.54M
- P/E (TTM)
- –
- Dividend yield
- –
Margins
Share of revenue, fiscal years 2012 to 2026
Gross margin
17.2%−14.9 pts over 5 years
Operating margin
-11.1%−2.6 pts over 5 years
Net margin
-11.5%−10.5 pts over 5 years
Growth rates
Compound annual growth to fiscal 2026
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +65.2% | +14.4% | +24.2% | +23.2% | |
| Gross profit | +59.5% | -11.1% | +9.6% | +19.1% |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2017 | FY2021 | FY2026 | Trend |
|---|---|---|---|---|
| Return on equity | -175.7% | -3.3% | -22.3% | |
| Return on assets | -51.3% | -1.6% | -13.9% | |
| Current ratio | 1.39 | 1.90 | 2.28 | |
| Debt to equity | – | 0.00 | 0.06 | |
| Net debt to EBITDA | – | 1.14× | 2.65× | |
| Interest coverage | -318.8× | -170.8× | -23.7× | |
| Inventory turnover | 2.2× | 3.5× | 7.1× | |
| Capex to revenue | 0.9% | 0.7% | 1.4% | |
| Diluted shares | 3M | 4M | 9M |
Where the cash went
Fiscal 2022 to 2026, five years combined
Precision Optics generated $8.64M from operations and spent $1.06M on capital expenditure, dividends and share buybacks. 100% of that went back into the business.
Generated
$8.64M
Used
$1.06M
Capital expenditure$1.06M100%Dividends$00%Share buybacks$00%
DuPont analysis
Return on equity split into margin, efficiency and leverage
Net margin-11.5%
×Asset turnover1.21×
×Equity multiplier1.60×
=Return on equity, FY2026-22.3%
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2026 | -11.5% | 1.21× | 1.60× | -22.3% |
| FY2025 | -30.3% | 1.04× | 1.64× | -51.8% |
| FY2024 | -15.4% | 1.04× | 1.66× | -26.7% |
| FY2023 | -0.7% | 1.15× | 1.73× | -1.4% |
| FY2022 | -5.9% | 1.37× | 1.85× | -15.0% |
| FY2021 | -1.0% | 1.69× | 2.03× | -3.3% |
| FY2020 | -14.4% | 1.43× | 2.25× | -46.4% |
| FY2019 | -9.0% | 1.36× | 2.54× | -31.2% |
| FY2018 | -8.7% | 1.87× | 3.84× | -62.6% |
| FY2017 | -31.9% | 1.61× | 3.43× | -175.7% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2026 against fiscal 2025
5of 9 tests passed in fiscal 2026. Scores of 7 to 9 are usually read as strong.
- ProfitableNet income above zero-$3.63M
- Cash generatingOperating cash flow above zero-$1.55M
- Return on assets improvedROA up on the prior year-34.2% → -18.3%
- Earnings backed by cashOperating cash flow above net income-$1.55M vs -$3.63M
- Less leverageLong-term debt to assets fell6.5% → 2.2%
- Better liquidityCurrent ratio rose1.64 → 2.28
- No dilutionShare count did not rise7M → 9M
- Gross margin improvedGross margin up on the prior year17.83% → 17.22%
- More efficientAsset turnover rose1.13 → 1.59